Trace Bio
Beaverton, US · Founded 2021 · 2 known investors
Trace Biosciences develops targeted fluorescent imaging agents, called Nerve Trace, that highlight nerves in real time during surgery so surgeons and surgical robots can avoid nerve damage. The technology is intended to make nerves visible across surgical specialties to prevent surgical nerve injuries.
Founders & leadership
CB
Connor BarthNamed on SEC filing
SG
Summer GibbsNamed on SEC filing
LW
Lei WangNamed on SEC filing
JS
Jonathan SorgerNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$8.3M disclosed across 1 round · 2026
▶$8.3MraisedAug 2026 · 19 investors · BiotechnologyRule 506(b)
▶$8.3MraisedAug 2026 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Connor BarthExecutive Officer, Director
- Summer GibbsExecutive Officer, Director
- Lei WangExecutive Officer, Director
- Jonathan SorgerDirector
- Offering amount
- $16.2M
- Amount sold
- $8.3M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $599.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $386.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Trace Bio do?
- Trace Biosciences develops targeted fluorescent imaging agents, called Nerve Trace, that highlight nerves in real time during surgery so surgeons and surgical robots can avoid nerve damage. The technology is intended to make nerves visible across surgical specialties to prevent surgical nerve injuries.
- Who are Trace Bio's investors?
- Trace Bio's investors include Elevate Capital, SciFounders.
- How much funding has Trace Bio raised?
- Trace Bio has disclosed $8.3M raised across 1 round.
- Where is Trace Bio headquartered?
- Trace Bio is headquartered in Beaverton, US.